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ABSTRACT

MIF-like Activi ty in Non-Stimulated and
Virus Infected Cell Cultures.
(Under the direction
of N. M. Burdash, Ph.D., and J. P. Manos, M.D.)

EVE vvELLING BROWN.

Macrophage migration inhibition factor

(MIF) is a lym-

phocyte-derived substance which plays an important role in
cell mediated immunity.

Soluble factors containing MIF-like

activity and produced by non-stimulated and virus-infected
non-lymphoid cells have also been reported.

In the present

study, a MIF-like factor was repeatedly detected in Buffalo
green monkey kidney cells infected with. mumps or herpes
simplex virus (HSV)

indicating that this substance is re-

producible and can be stimulated by a RNA and a DNA virus.
Wistar-38

(WI-38) cell cultures also increased production

of this substance in response to mumps but not HSV infecti.on,
indicating that the production of this factor is not linlited

to one cell line, and is not necessarily induced by all
viruses.

A factor which stimulated the spread of macro-

phages was also found to be induced in WI-38 cells by both

viruses, suggesting another possible defense mechanism by
non-lymphoid cells in response to 'viral infection.

The

ability of non-stimulated WI-38 cells to produce MIF-like
activity was also confirmed, and this factor could be
further stimulated or opposed by viral infection.
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INTRODUCTION
Activated thymus-derived lymphocytes (T cells) release a
number of physiologically-active sUbstances which can be
detected in vitro.

These substances were termed "lymphokines"

by Dumondeet al.,

(1) whose work showed that these cell-free,

soluble factors were generated as a result of the interaction
of sensitized lymphocytes with specific antigen.

One of the

most studied lymphokines is migration inhibitory factor (MIF).
This substance inhibits the migration of macrophages in the
vicinity of the sensitized, activated T cells.

When macro-

phages are placed in a capillary tube within a tissue culture
chamber, they migrate from the tube in a fan-like pattern
over the glass wall of the

chamber~

If MIF is present in the

chamber, the macrophage migration is inhibited.
MIF Production

~ L~phocytes

Stemming from early work of Rich and Lewis (2), George
and Vaughn (3) devised experiments to provide information on
the possibility of using macrophages as an in vitro model for

delayed hypersensitivity.

Guinea pigs were sensitized with

b~cille Calmette-Gu~rin (BCG) , an attenuated mutant of Myco-

bacterium tuberculosis.

Migration studies were then done on

peritoneal exudate cells (PEC) , spleen cells, or lynph node
cells from these animals with purified protein derivative

2
(PPD) of tuberculin added to the culture medium.

PPD is the

antigen used in skin testing for delayed hypersensitivity to
tuberculosis.

The PEe from sensitized animals were strik-

ingly inhibited as compared to culture media without PPD.
Inhibition of spleen cells from the same animals was less
conspicuous or absent.
David et al.,

(4) using a modification of the method of

George and Vaughan, confirmed their results by finding that
PEe taken from animals with delayed hypersensitivity to tuberculin were consistently and markedly inhibited by physiologic amounts (0.75 to 1.5 mcg/ml) of PPD.

The effect was

reproducible, and the method seemed well suited for further

study of the mechanisms of cell mediated _immunity (eMI).
In further work David (S) demonstrated that following a
24 hour incubation of sensitized lymphoid cells with specific
antigen, a non-dialyzable substance was detected in the cellfree supernatant which inhibited the migration of normal PEe.
This soluble substance was also found to be heat stable at
56°C for 30 minutes.
Bennett and Bloom (6) partially purified MIF and estimated its molecular weight to be approximately 67,000 daltons.
Recent estimates of molecular weight for MIF range from 10,00030,000 (7) and from 45,000-67,000 (8).

By injecting this

substance intradermally into normal guinea pigs, a reaction
resembling delayed hypersensitivity (induration, erythema,
and mononuclear cell infiltration) was produced.
~

Various

3
other substances have been shown to stimulate MIF production
including soluble (7) and cell-associated (10) tumor antigens, fungal (II, 12), bacterial (12), and viral (13)
antigens.
It has been shown that mitogens are capable of inducing

·the production of lymphokines by non-sensitized lymphocytes.
Pick et al.,

(14) cultured oil-induced peritoneal exudate

lymphocytes (PEL) and lymph node lymphocytes from normal
Hartley strain guinea pigs with concanavalin A (Can A), a
plant mitogen.

A factor which inhibited the migration of

macrophages in vitro was liberated into the culture medium.
The mitogen-induced MIF was similar to antigen-induced MIF in
time of release and molecular weight.

Supernatants of PEL

incubated without mitogen did not inhibit macrophages.

MIF

was previously considered to be an antigen-specific in vitro
correlate of cellular immunity.
On the basis of indirect evidence it had been assumed
that T cells were the sale source of lymphokines.

However,

several reports indicate that bone-marrow derived lymphocytes
(B cells)

might be a source of MIF.

Yoshida et al.,

(15)

demonstrated the production of MIF in a B cell rich population
using PPD as an antigen.

The B cell population was separated

from the T cells by an agglutination technique.

The result-

ing cell population, which contained approximately 10% T cells,
was found to produce MIF when cultured with PPD.

A dose

response curve essentially negated the possibility that the
T cells were responsible for the MIF.

PPD was able to activate

4
lymphocytes from non-immune as well as immune guinea pigs in
their studies.

Therefore, i t appeared that the MIF-inducing

ability of PPD might be the result of a mitogenic effect.
MIF was also produced after the B cells were incubated with
lipopolysaccharide, a known B cell mitogen.

In contrast, Rocklin et al.,

(16) showed that B cell

populations derived from the blood of patients exhibiting
cutaneous delayed hypersensitivity to PPD, Candida, or streptokinase-streptodornase produced MIF when stimulated in vitro
by the specific antigen.

Band T cell populations were

separated by affinity column chromatography and found to be
95-98% pure by demonstration of 98% immunoglobulin bearing
cells

(B cells), 2% E rosetting cells (T cells), and less

than 2% monocytes.
MIF Production

~

Non-Lymphoid Cell Lines

Studies by several investigators have shown that MIF-like
activity has been released by a variety of cell types other
than lymphocytes, suggesting that MIF is not solely a lymphoid
product.

Papageorgiou et al.,

(17)

found that the migration

of guinea pig rnacropbages and cultured human lymphoid cells
was inhibited by supernatant fluids from a human cervical
carcinoma cell line (HeLa) and from hamster malignant brain
tumor.

MIF activity was also fourid in human embryonic lung

supernatant but was considered insignificant for their assay
system.

The MIF from the HeLa supernatant was non-dialyzable

and heat stable for 30 minutes at 56 o Co

One of their con-

clusions was that MIF might be a product of any activated cell.

5

Tubergen et al.,

(18) also found MIF activity in non-

lymphoid, continuous cell lines.

When fluids from a mouse

fibroblast 3T3 cell line were assayed, actively growing 3T3
fibroblast cells produced significantly greater quantities
of MIF than did contact inhibited cells.

When synchroniza-

tion of growth was obtained in a human lymphoid cell line,

MIF activity was detected only In the S phase of the mitotic
cycle, however, cell division was not required for production
of MIF.

Their conclusion was that MIF may be a product of

mitotic activity.

It was theorized that many stimuli,

immunologic or non-immunologic, which might activate a cell

to enter the S phase would result in release of MIF.
MIF-Like Activity in Virus-Infected Tissue Culture
Viruses, as

macromol~cules,

are capable of inducing a

humoral immune response in an immunocompetent host with subsequent antibody production.

However, the influence of

cellular immunity on various viral, fungal, and other intracellular parasitic infections has not been satisfactorily
explored in vivo.

Enhanced susceptibility of individuals

with defective cellular immunity to viruses, fungi, and parasites suggests the importance that cellular immunity plays
in resistance and recovery to diseases caused by these
organisms.
Tubergen and Oldstone (19) have demonstrated the release
of MIF· from spleen cells of virus-infected animals when these
cells were incubated in vitro with the infecting virus.

Active

6

or ultraviolet inactivated viruses were both capable of
causing production of MIF.

Mumps, lactic dehydrogenase, and

lymphocytic choriomeningitis viruses were used.
Flanagan et al.,

(20) demonstrated MIF-like activity in

supernatant fluids from African green monkey kidney cells
(BGM) infected with mumps virus or Newcastle disease virus
(NDV).

The MIF-like activity was not found in supernatant

fluids of uninfected cell cultures.

Ultraviolet inactivation

of the viruses abolished their ability to induce production
of MIF-like activity in the cell cultures.

It was hypothe-

sized that virus-induced MIF may play a role in host defense
mechanisms to viral infections.

PURPOSE OF STUDY
With the growing amount of evidence indicating that MIFlike substances are produced by cells other than T lymphocytes,.
the possibility of such a substance's being another host
resistance mechanism has been hypothesized.

Since mumps and

NOV, both paramyxoviruses, have been found to induce MIF-like
activity in a BGM cell culture, the present study was conducted to determine if this activity was limited to

para~

rnyxoviruses or whether a virus from an unrelated group could
induce MIF.

Alternately we wanted to determine whether the

MIF produced was unique to a particular cell culture line (BGM)
or could be produced by other cell lines in response to viral
infection.

MATERIALS AND METHODS
Cell Lines
The BGM Line of African green monkey kidney cells and
human embryonic lung (WI-38) cells, both from Microbiological
Associates (MBA), were used in this investigation.

Both cell

lines were maintained with Eagle's minimal essential medium
(MEM) in Earle's saline supplemented with 100 units of
penicillin and 100 mcg of streptomycin (P-S) per ml plus 1%
L-glutamine.

The MEM used to feed the BGM cells also con-

tained 0.5% newborn calf serum; the MEM for the WI-38 contained 0.5% heat-inactivated (56°C for 30 minutes) fetal calf
serum.

Each cell culture tube was observed for the presence

of a complete cell monolayer before inoculation with virus.
Virus Preparations
The ABC·strain of mumps virus (courtesy Dr. Maurice R.

Hilleman,

Mer~k

Institute) was passed four times in each cell

line, with the fourth passage used as the stock virus throughout the project.

Mumps virus was harvested on the fifth day

of each passage and the stock virus was titered on the fifth
day following inoculation by hemadsorption (21).

The titer of

the stock virus, calculated according to the method of Reed and

Meunch (22), was 105 Tissue Culture Infectious Dose
(TCID SO )
50
in BGM cells and 10 4 • 5 TCID SO in WI-38 cells, The identity of
mumps was confirmed by neutralization with mumps antiserum (21).

8

Herpes simplex virus

(HSV) was obtained from a Medical

University of South Carolina opthalmology clinic patient and
was identified by pocks formation on the chorioallantoic membrane of chick embryo and by neutralization with specific
antiserum in WI-38 cells (21).

HSV was passed in both cell

lines when the cytopathogenic effect (ePE) was three plus
(3+).

The titer of the fourth pool, or stock virus, was 10 5

TCID SO in both cell lines,
Inoculation of Cell Cultures

It was known that mumps virus induced a significant amount
of MIF-like activity in BGM cells at 48 hours (20).

To deter-

mine if variations in quantity of virus or time of incubation
had any effect on MIF production, three concentrations:

10,

100, and 1000 infectious units (IU) of mumps virus were prepared and inoculated into BGM cells.
incubated for 24, 48, or 72 hours.

Each concentration was
HSV was also diluted to

10 , laO, and 1000 lU, inoculated into BGM cells, and incubated
for 24, 48, or 72 hours.

The second half'of this investigation

was to ascertain if either mumps or HSV could induce MIF-like
activity in WI-38 cells, therefore the above experiments were
repeated using WI-38 cells rather than BGM cells (Figure 1).
Filtration of Pools
Each pool [pool refers to cell culture medium (MEM) pooled
from one cell line, inoculated with one viral concentration
and incubated for one time period] was ultra-filtered with
a Swinnex (Millipore Corporation) filtering system containing

Stock Virus*

100 . · IU

10 IU

24 hrs.

48 hrs.

MIF

Figure 1.

I

MIF

72 hrs.

24 hrs.

I

I

MIF

MIF

48 hrs.

I
MIF

1000 IU

72 hrs.

24 hrs.

48 hrs.

I

t

I

MIF

MIF

MIF

72 hrs.

I
MIF

Flow chart illustrating how the pools for MIF determinations were obtained.
Stock viruses were diluted to 10, IO~ or 1000 IU, inoculated into BGM or
WI-38 cells and incubated for periods of 24, 48, or 72 hours. MIF determinations were done on each pool. Each MIF designated represents the mean
of 12 determinations (three groups of two chambers with two capillary tubes/
chamber).
.

*

1. Mumps in BGMj 2. HSV in BGMi 3. Mumps in WI-38; 4. HSV in

WI-38~

\0

10
a 0.05 micrometer filter to remove viral particles.

Each

filtrate was inoculated into cell cultures to determine
sterility and then frozen at -70°C until. assayed.
Assays
-MIF ---=--Twelve MIF determinations (three groups of two chambers
with two capillary tubes/chamber) were done on each pool.

Controls for these experiments were media from uninoculated
cell cultures incubated for the same time period.

Fluids

from uninoculated cell cultures (BGM, WI-38) were also assayed
for MIF-like activity (background MIF) using MEM alone as the
control ..
Collection of Macrophages
MIF assays were done according to David's (4) method with
slight modifications.
used were sterile.

All reagents, materials, and equipment

All materials and equipment were washed,

rinsed ten times in tap water, and ten times in distilled
water before sterilization.

Normal Hartley strain female

guinea pigs (Charles Rivers Breeders) weighing 400-500 grams

were injected with 30 ml of light mineral oil (Hurneo Laboratories).

After three days the peritoneal cavity was washed

out with 150 ml of cold Hank's balanced salt solution (BSS)

~

The emulsion was collected in a 250 ml separatory funnel and
allowed to settle for 10 minutes.

The effluent was collected

in plastic centrifuge bottles which were spun at SoC for 15
minutes at 450 X gravity (G)~

The supernatant was aspirated,

and the peritoneal exudate cells (PEe) were washed three times
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in cold Hank's BSS.

The final packed cells were resuspended

to a 10% cell suspension in RPM! 1640 supplemented with 1%
glutamine and 10% heat-inactivated guinea pig serum (Pelfreez).
Assay of Cell Culture Pools
Heat-inactivated guinea pig serum was added to each pool
to a final concentration of 15%.

Nonheparinized capillary

tubes were filled with the macrophage suspension, sealed at
one end with Sealease (Clay-Adams), and centrifuged for five
minutes at 250 X G to pack the macrophages.
were cut at the cell-fluid interphase.

The capillaries

Two packed cell

capillary sections were placed on dabs of silicone on the

bottom cover slip of each MIF chamber.
sealed in place with silicone.

The cover slips were

All chambers were filled with

the filtered viral pools or the control fluids and incubated
for 24 hours 'at 370C.
Determination of Migration Index
After incubation the MIF chambers were placed on the stage
of an American Optical microscope with a projecting prism (Leitz).
Areas of migration were drawn on graph paper and then measured
with a planimeter (Gelman Instrument Company).

Migration index

(MI) was calculated as follows:
MI=Mean area of migration of macrophages in virus pools
X 100
Mean area of migration of macrophages in control fluids
Each mean was calculated from the areas of migration of 12
capillary tubes
tubes/chamber) •

(three groups of two chambers with two capillary

12
Viability Studies
Macrophage viability was determined by two methods:

1)

After measurement of area of migration, the migration cells

were recovered from the chambers and viability was ascertained
by trypan blue exclusion.

2) The chambers were returned to

the incubator an additional 48 hours and areas of migration

were redrawn superimposed over the area of migration at 24
hours to demonstrate reversibility of migration inhibition.
Confirmation of Peak MIF Activity
The dilution of virus giving peak MIF-like activity was reinoculated into the appropriate line of cell cultures and incubated for the time period giving the greatest response.

The

supernatant fluids were filtered and assayed for'MIF activity
as previously described.

~

Dose Response Curves
In an attempt to quantitate the MIF-like activity or MSFlike activity produced, dose response curves were done.
The original pool giving the peak

MIF~like

1)

response in BGM

cells (10 IU of mumps incubated for 48 hours) was serially
diluted with its control.

2) The original pool giving the

peak MIF-like response in WI-38 cells (10 IU of mumps incubated for 48 hours) was diluted as above.

3) A pool containing

peak inhibitory activity was diluted with a pool containing
peak stimulatory activity.

4) A pool containing peak stimula-

tory activity was diluted with a pool containing peak inhibitory
activity.

MIF assays were done on the dilutions, the undiluted

pools, and their respective controls.

RESULTS
Table 1 compares the MIls of mumps and HSV in BGM and
WI-38 cells at varying dilutions and time periods.

In BGM

cells any MI of mumps which varied by 26 or more from the
control value of 100 was significantly different, whereas
HSV-infected BGM cells had to vary by 31 or more to be
significantly different.

Ten and 100 IU of mumps virus in-

cubated for 48 hours in BGM cells and 1000 IU of mumps
incubated for 72 hours induced a MIF-like activity, which
was significantly different from the controls.

Peak MIF-like

activity was exhibited in the pool of 10 IU of mumps incubated for 48 hours.

Only the pool of 1000 IU of HSV-

incubated for 48 hours was found to induce a significant
MIF-like activity.

Uninoculated BGM cells did not produce a

significant amount of MIF-like activity when fresh culture
medium was used as a control (Table 2).
Uninoculated WI-38 cells produced a significant amount

of MIF-like activity; MEM which had been incubated for the
same period of time was used as the control (Table 2).

In

this cell line any MI value of mumps which varied from the
control by 25 or more was significantly different, while HSVinfected WI-38 cells had to vary by 21 or more to be significantly different.

In this cell line, 10 and 1000 IU of mumps

Table 1.

Comparison of Migration Indices a
Cells and WI-38 Cells.

(MI) of Mumps Virus and HSV in BGM
~---

MI of Mumps Virus Pools b
Cell
Line

_ BGM

MI of HSV Pools

Infect.
Units
24 hrs.

48 hrs.

10

+
107-15.9

100

104±15.7

1000
Contro1sc

72 hrs.

24 hrs.

48 hrs.

72 hrs.

57±12.6*

86±14.3

8l±14.4

l20!17.4

84±14.6

71:t13.3*.:--

76::13.7

118±17.3

95±lS.4

69±13.6*

76±13.7

87±14.4

74:!:13.5*

l21±17.5

56±12.8*

86±14.7

100

100

100

100

100

90±9.2

losilO.l

i

100

10

94±12.3

73~11.l*

l37:t15.1*

100

89~12.0

80±11.4

l24±14.2

lOO±9.7

94±9.4

123±10.8*

1000

lO2:!12.8

61!10.5*

103±13.l

1l3±10.3

88±9.l

l57±12.7*

111±lO.2

WI-38
C

Controls
a.
b.

c.

*

100

100

100

100

100

100

Calculated as: mean area of test pool migration/mean area of uninfected control fluid
X 100. Mean is the average of 12 capillary tubes from three MIF determinations done
in duplicate, each containing two capillary tubes.
Pool is defined as: cell culture medium (MEM) pooled from one cell line inoculated
with one viral concentration incubated for one time period.
Controls were culture media collected from the same lot number of uninoculated cell
cultures which were incubated for the same time periods as the virus infected cell
cultures.
Significantly different from control, P<O.05.

f-I
~
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Table 2

Background MIF-like activity In uninoculated BGM
and WI-38 cell cultures.
r

MI

Time in hours

BGM

WI-38

24

94

56

48

87

77

72

81

46

100

100

MEM Control
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virus incubated for 48 hours were able to increase the production of MIF-like activity with the peak occurring in the
1000 IU pool.

HSV was not found to increase a MIF-like

activity in WI-38 cells.
It can also be seen from Table I that in WI-38 cells at
72 hours, 10 IU of mumps and 100 and 1000 IU of HSV had MI's

which exceeded the control by a significant amount with MIls
of l37, 123, and 157 respectively, indicating the production
of a probable macrophage stimulation factor

(MSF).

To determine reproducibility of results, dilutions giving

peak MIF-like activity were reinoculated into cell cultures
and incubated for the appropriate time periods.

The filtered

culture media were assayed for MIF activity as described previously.

Table 3 shows that comparable MIF-like activity was

induced in each case when the experiments were repeated.
The original pools from 10 IU of mumps in both cell lines,

which had been incubated for 48 hours, were serially diluted
to determine the highest dilution containing MIF-like activity
(Figure 2).

The repeat MI's of the undiluted BGM and WI-38

pools, which had been stored at -70 o C, were 65 and 69 respectively.

The original MIls (Table 1) of these pools were

57 and 73 respectively.

The differences between the repeat

and original MI values were statistically insignificant.

The

diluent for each was the culture fluid from the original,
respective controls.

Figure 2 shows that with serial dilution,

MIF-like activity was lost.

Although the 1:4 dilution of the

mumps in WI-38 shows a decreased MI, it was not significantly
different (P<O.OS) from the control.

Table 3

Reproducibility of peak MIF-like activity of mumps and HSV in BGM and WI-38 cells.

Mumps
Cell
Line

Infect.
Units

10

HSV

48 hrs ..
1st MI
2nd MI

57

48 hrs.
1st MI
2nd MI

59
~-

72 hrs.
1st MI
2nd MI

-

-

-

-

69

50

56

52

-

-

100

-

1000

-

-

~ontrols

100

100

100

100

100

100

10

73

74

-

-

-

BGM

100

-

-

-

-

1000

61

76

88

90

Controls

100

100

100

100

WI-38

I

-

-

.....
~

18

180

170
U)

160

OJ
()

.r-I

'0
~

150

140
130

H

120
~

0
-r-I

110
100

+J

m
J...f

01
-,...f

90
80

7

~

60
50

1:2

1:1
D i

Figure 2.

1 u t

i

1:4
o n s

Pools of peak MIF-like activity from BGM
and WI-38, serially diluted with their
respective controls. • . • , 10 IU of mumps
incubated 48 hours in BGMi $-.-0 10 IU of
mumps in WI-38.
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Dose response curves were also done to ascertain: 1)
the effect of diluting a pool containing inhibitory activity
with a pool containing stimulatory activity and; 2) the effect
of diluting a pool containing stimulatory activity with a pool
containing inhibitory activity.
The pool giving peak inhibitory response in BGM was
(original MI of 57) serially diluted with the mumps pool from
WI-38

(probable MSF) which had the highest index of migration

(MI of 137).
cells.

The control was MEM from uninoculated BGM

By serially diluting the amount of inhibitory factor,

the MI rose from 76 to 173 (Figure 3).
The HSV pool derived from WI-38 cells which contained
MSF-like activity (MI of 157) was serially diluted with the
HSV pool derived from BGM cells containing peak inhibition
(MI of 56).

Decreasing the quantity of MSF did not give MI's

which were significantly different from the control (Figure
3).

The control was the original culture medium from un-

inoculated WI-38 cells.
Figure 4 shows a comparison of the mumps-induced peak
inhibitory pool in BGM serially diluted with its original control to the same inhibitory pool serially diluted with a
mumps-induced peak stimulatory pool from WI-38.
MIF-like activity pool was

dilute~

When the peak

with the MSF-1ike activity

pool, there was a rapid increase in the MI at 1:4.

However,

when the peak MIF-like pool was diluted with its control, the
1:4 dilution had an MI which was approximately the same as its
control.
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Dilutions of pools containing inhibitory and
stimulatory activity..
"
mumps-induced peak
MIF-like activity pool in BGM diluted with mumpsi~U~d peak MSF-like activity pool in WI-38.
.
,HSV-induced peak MSF-like activity in
WI-38 diluted with the HSV-induced peak MIF-like
activity in BGM.
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Comparison of effects of dilution of the mumpsinduced peak MIF-like activity pool when diluted
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- , Pool of 10 IU of mumps incubated 48 hours in BGM serially diluted with its
control;~
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diluent for a mumps-induced peak inhibitory pool
from BGr~l.

22

Cell Viability
Inhibition of macrophage migration was not due to dead
cells.

Reincubation of chambers which showed inhibition for

an additional 48 hours after the initial 24 hour period,
showed that the MIts equaled or exceeded the control MI's.
Also the migration cells were recovered from chambers giving
peak inhibition and were compared to recovered control macrophages by trypan blue exclusion.

Test macrophages had a

viability of 71% as compared to 70% for the control macrophages.

DISCUSSION

Analysis of theMI's in BGM cells shows that inoculation
of this cell line with mumps, a RNA paramyxovirus, induced a
statistically significant MIF-like factor in three of the
nine pools.

Furthermore, two other pools produced a sub-

stantial amount of MIF, although not statistically significant.
The peak MI of 57 was produced in the 10 IU pool incubated for
48 hours.

This is in agreement with Flanagan et al., (20) who

reported a MI of 56.1 with mumps in BGM cells incubated for
48 hours.

He also found that NDV, another paramyxovirus,

produced a MI of 59.5 in BGM cells when incubated for 48
hours, further indicating there is a definite inducible substance produced in this system which inhibits macrophage
migration.
When HSV,a DNA virus of the herpes group, was inoculated
into BGM cells, the following reactions were observed.

One

thousand IU incubated for 48 hours and 100 IU incubated for
72 hours produced a significant amount of MIF-like activity
with MIls of 56 and 69, respectively.

Repeating these experi-

ments produced similar MI's, indicating that the MIF-like
factor is reproducible and can be induced by at least one
other virus, one which comes from a widely different group,

and which contains DNA instead of RNA in its genome.
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To determine if induction of MIF-like activity by a virus
was unique to BGM, a continuous, epithelioid line originating
from monkey kidney, mumps virus was inoculated into WI-38
cells, a diploid, fibroblastic cell line originating from
human embryonic lung.

Forty-eight hours after inoculation

of mumps virus into WI-38 cells, a significant amount of macrophage inhibition was induced.

Ten and 1000 IU pools had MI's

of 73 and 61 respectively, when compared to supernatant fluids
from uninoculated WI-38 cells incubated for the same period
of time.

One other statistically significant peak occurred

with mumps in WI-38 cells.

Ten IU incubated for 72 hours pro-

duced a MI which was 37% greater than the uninoculated control,
indicating that the macrophages were stimulated rather than
inhibited.

A MI of 124 was produced by 100 lU of mumps incu-

bated for 72 hours, but was just· within the approximate
significance range (.:: 75 or

~

125) •

It had been reported by Tubergen et al.,
orgiou et al.,

(17)

(18) and Papage-

that uninoculated WI-38 cells produced MIF--

like activity with MIls of 74 and 81 respectively.

In the

present study, comparison of MI's of uninoculated cell cultures
and growth medium (MEM) showed that BGM cells did not produce significant amounts of background MIF-like activity.
However, the WI-38 cells did produce significant amounts of
inhibitory activity (MI's ranging from 46-77) when culture
medium was used as the control, indicating that nonstimulated
WI-38 cells have the capacity to produce a substance which
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inhibits macrophage migration.

Addition of the mumps virus

to this cell culture enhanced migration inhibition of macrophages when compared to uninoculated cell culture controls,
further indicating that this virus increases the capacity of
these cells to produce this substance as a response to viral
infection.

Inoculation of WI-38 cells with HSV did not

induce a greater production of inhibitory factor in this cell
line in any dilution or time period.

However, in two pools

of HSV, 100 and 1000 IU, both incubated for 72 hours, the
macrophages spread more than the control with MI's of 123
and 157 respectively, again indicating the induction of MSFlike activity.
Papageorgiou et al.,

(17) found MIF-like activity in a

'number of non-lymphoid cell lines, including HeLa, human
embryonic lung, rat thymus, and malignant hamster brain tumor.
The MIF's produced by lymphoid and non-lymphoid cell lines
were found to be similar in the following aspects: a) inhibition
by crude supernatants of cultured lymphoid cell migration; b)
I

peak inhibition activity in the same cell fractions following separation by ultrafiltration; c) similar elution profiles
from .Sephadex G-SOi d) non-dialyzabilitYi e) heat stability
at 56°C; f) molecular weight between 12,400 and 25,000.
Yoshida et al.,

(8) demonstrated that viral-induced MIF

(M1Fv) shared properties with antigen-induced, lymphocytederived MIF (MIF L ) in vitro and in vivo.

Both MIFv and MIFL

were removed from supernatants by passage through an
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immunoadsorbent column containing antibody raised against
the MIF L •

In vivo the M1Fv was as capable as conventional

MIFL in suppressing cutaneous manifestations of delayed hypersensitivity when injected intravenously into guinea pigs
sensitized to diphtheria toxoid-antitoxin and then skin
tested.
While no physiocochemical characterization of the inhibitory or stimulatory factors were done in the present study,
it appears that tissues of different stem cell origin may be

predisposed to produce MIF or MIF-like substances, whose effects
are not dissimilar.

Whether there is a single MIF molecule or

several different molecules with similar activities remains
to be seen.

The fact that a substance which inhibits macro-

phage migration is produced by different cell lines, with or
without stimulation, indicates a more universal or diverse role
for this substance.
virus 40 (SV40)

I

Production of inhibitory factors by Simian

polyoma, and Rous sarcoma viruses in virus-

transformed, lymphoid cells as reported by Paste et al.

(7),

represents a potential mechanism of modifying eMI to respond
to local tumors.

Since this factor has also been produced in

vivo by non-lymphoid cells in response to mumps virus infection
in monkeysl MIF-like substance may represent another nonspecific,
anti-viral agent such as interferon (26).
Since HSV in WI-38 cells produced macrophage stimulation,
but not inhibition, the most probable explanation is that herpes
induced a stimulation factor in sufficient concentration to
negate the effect of the WI-38 cells'inhibitory factor.

MSF
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has been described by several investigators as being induced
by tuberculin (23,24, and 25), brucella antigen (20), and also

present in fetal calf serum (25), and we believe induced by
viruses in WI-38 cells.
Fox et ala

(25), indicate that MSF is often not detected

in stimulated guinea pig lymphoid cells, because its action is
opposed by MIF.

However, removal of MIF by chromatography on

DEAE-Sepbadex A-25 reveals the presence of MSF.

In an attempt

to evaluate the inhibitory and stimulatory factors in this
investigation, pools containing each were thawed and two dose
response curves were done.

A MIF pool from the BGM cells was

serially diluted with a MSF pool from the

WI~38

cells.

At the

time these experiments were done, neither undiluted pool was
significantly different from its control.

As the proportion of

the inhibitory factor in relation to the stimulation factor
decreased, an ascending, straight-line curve was demonstrated,
indicating that the inhibitory effect of the MIF-like factor was
rapidly diluted out.

However, the opposite was not true.

When

the proportion of stimulation factor, in relation to inhibitory
factor, was decreased, the MI's were not significantly different
from the controls at any dilution up to 1/16, indicating again
that the MSF-like activity was present in high concentrations
and was not diluted out.

The biologic significance of this

stimulatory substance awaits clarification, but it is interesting to note that both inhibitory activity and stimulatory activity
can be produced by the same cell line.
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The use of established cell lines, both lymphoid and nonlymphoid, stimulated and non-stimulated, as a source of production of these inhibitory and stimulatory molecules presents
the advantages of: a) genetic uniformity similar to inbred
animal strainsi b) ease of growing large numbers of cells; and

c) economy of operation.

Hopefully these factors will encourage

even more investigation in those areas.

Further separation,

purification, and comparison of inhibitory and stimulatory
substances should lead to a better understanding of the number
of substances, their nature, and their relation to eMI.
In summary, a MIF-like factor was found in BGM cells
infected with mumps or HSV.

The induction of this factor was

reproducible and was shown to be stimulated by a RNA and a DNA
virus.
The ability of non-stimulated WI-38 cells to produce MIFlike activity was also confirmed, and production of this factor
could be further stimulated or opposed by viral infection.
WI-38 cells were found to produce an increased amount of this
inhibitory substance in response to mumps infection, but not to

HSV 1 indicating that the production of this factor in response
to viral infection is not limited to one cell line, and production is not enhanced by all viruses.
Furthermore, a stimulating factor was found to be induced

In WI-38 cells by both viruses, indicating yet another possible
defense system in response to viral infection.

This stimulation

factor seemed to be present in much higher quantities than the
inhibitory factor.
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